Stock Analysts

LaSalle Acquires California Hotel (HST) (LHO)

LaSalle Hotel Properties ( LHO ), a real estate investment trust (REIT), has recently acquired a 120-room full service luxury resort titled L’Auberge Del Mar in Del Mar, California. The property was purchased from an unnamed seller for $76.9 million. Set on 4.5 acres overlooking the picturesque Pacific Ocean, the hotel is strategically placed in close proximity to several leisure and business demand drivers of the region […]

Stock Analysts

Diamond Foods Reports Dismal 4Q (CAG) (DMND) (MDLZ)

Diamond Foods Inc. 's ( DMND ) fourth-quarter fiscal 2012 earnings of 5 cents per share plummeted 78% from the prior-year earnings of 23 cents per share, primarily driven by poor top-line performance, increased costs and soft margins. The fourth-quarter earnings were also way below the Zacks Consensus Estimate of 41 cents. […]

Stock Analysts

Earnings Preview: Ciena (CIEN) (T) (VZ)

Telecommunications network specialist Ciena Corp. ( CIEN ) is scheduled to release its fiscal fourth quarter 2012 earnings results before the opening bell on December 13, 2012. In the run-up to the earnings release, we do not notice any revision in analysts’ estimates […]

Stock Analysts

Canadian Imperial Posts Solid 4Q (CM) (RY)

Last week, Canadian Imperial Bank of Commerce ( CM ) reported its fiscal fourth quarter 2012 (ended October 31) adjusted earnings per share of C$2.04. This was up nearly 15% from the prior-quarter earnings of C$1.78. For fiscal 2012, Canadian Imperial’s adjusted earning were C$8.07 per share compared with C$7.57 recorded last year. […]

FDA Approval

NeuroQuest Close to Validation Trial for Biomarker Platform in Diagnosis of Alzheimer’s

NeuroQuest Close to Validation Trial for Biomarker Platform in Diagnosis of Alzheimer’s PR Newswire TEL AVIV, Israel, December 10, 2012 TEL AVIV, Israel , December 10, 2012 /PRNewswire/ — NeuroQuest , a company of the Trendlines Group’s Misgav Venture Accelerator is moving quickly towards an important validation trial for novel blood-based immune biomarkers for the diagnosis of Alzheimer’s disease. The company’s biomarker platform for neurodegenerative diseases is based on the research of Prof. Michal Schwartz , Chair of Neuroimmunology at the Weizmann Institute of Science who pioneered the concept of Protective AutoImmunity. […]

Mergers & Acquisitions

Enerplus Announces Guidance for 2013 and Acquisition of Additional Bakken Interests in Montana

Enerplus Announces Guidance for 2013 and Acquisition of Additional Bakken Interests in Montana Canada NewsWire CALGARY, Dec. 10, 2012 This news release includes forward-looking statements and information within the meaning of applicable securities laws. Readers are advised to review the “Cautionary Note Regarding Forward-Looking Information and Statements” at the conclusion of this news release […]

Momentum Stocks

NYSE Euronext (NYX) – Bear of the Day (NYX)

NYSE Euronext's ( NYX ) third quarter earnings plunged year over year based on weak volumes and pricing across trading venues, which led to a reduced top line and lower operating margin. However, while low cash position and high debt raised the concerns of rating agencies, capital deployment remained intact. The launch of NYPC platform, new data centers and IRS derivatives on U.S […]

Momentum Stocks

Virtus Investment Partners – Momentum (VRTS) (VRTS)

Earnings momentum for Virtus Investment Partners, Inc. ( VRTS ) has been advancing since this asset management company posted impressive third quarter results in late October, which included an earnings surprise of 16.0%. With a solid year-to-date return of 48.6%, this Zacks #1 Rank (Strong Buy) stock hit a new 52-week high on December 3. […]